Cell Signaling Technology

Product Pathways - Cell Cycle / Checkpoint

Phospho-Rpb1 CTD (Ser2/5) Antibody #4735

DNA-directed RNA polymerase II largest subunit   POLR2A   RNA pol   RNA polymerase II 220 kd subunit   rnapII   RPB1  

No. Size Price
4735S 100 µl ( 10 western blots ) ¥4,050.00 现货查询 购买询价 防伪查询
4735 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse,Rat, Endogenous 250 Rabbit
IHC-P 1:25

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting, IHC-P=Immunohistochemistry (Paraffin),


Species predicted to react based on 100% sequence homology: Hamster, S. cerevisiae,

Specificity / Sensitivity

Phospho-Rpb1 CTD (Ser2/5) Antibody detects endogenous levels of Rpb1 when the carboxy-termial domain heptapeptide repeat [Tyr1,Ser2,Pro3,Thr4,Ser5,Pro6,Ser7] is dually phosphorylated at Ser2 and Ser5 and singly phosphorylated at either Ser2 or Ser5.Phospho-Rpb1 CTD (Ser2/5) Antibody能够检测内源性羧基末端结构域七肽重复序列[Tyr1,Ser2,Pro3,Thr4,Ser5,Pro6,Ser7]丝氨酸(2,5位)双磷酸化和丝氨酸(2,5位)单磷酸化的Rpb1蛋白。

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Ser2/5 of the Rpb1 CTD heptapeptide. Antibodies are purified by protein A and peptide affinity chromatography.该多克隆抗体是由合成的针对Rpb1蛋白CTD结构域七肽序列丝氨酸(2,5位)的磷酸化肽段免疫动物,采用蛋白A和多肽亲和层析技术纯化生产的。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma, showing nuclear localization, using Phospho-Rpb1 CTD (Ser2/5) Antibody.免疫组织化学方法检测石蜡包埋人类肺癌组织,显示核定位,使用的抗体为 Phospho-Rpb1 CTD (Ser2/5) Antibody。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Phospho-Rpb1 CTD (Ser2/5) Antibody in the presence of control peptide (left) or antigen-specific peptide (right).免疫组织化学方法检测石蜡包埋人类结肠癌组织,使用的抗体为 Phospho-Rpb1 CTD (Ser2/5) Antibody,左图为与对照多肽共孵育,右图为抗原特异性多肽共孵育。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human renal cell carcinoma, untreated (left) or λ phosphatase-treated (right), using Phospho-Rpb1 CTD (Ser2/5) Antibody.免疫组织化学方法检测石蜡包埋人类肾细胞癌组织,分为非处理组(左图)或λ磷酸酶处理组(右图),使用的抗体为 Phospho-Rpb1 CTD (Ser2/5) Antibody。

Western Blotting

Western Blotting

Western blot analysis of extracts from MCF-7 cells, untreated or treated with doxorubicin (0.5 μM, 36 h), doxorubicin followed by λ Phosphatase NEB#P0753 (10,000 Units/ml, 1 h), nocodazole (50 ng/ml, 36 h) or nocodazole followed by λ Phosphatase, using Phospho-Rpb1 CTD (Ser2/5) Antibody (upper) or p53 Antibody #9282 (lower).Western blot方法检测MCF-7细胞,分为非处理组,阿霉素(0.5 μM)处理36小时组,λ磷酸酶(10,000 Units/ml,NEB#P0753)处理1小时后阿霉素处理组,诺考达唑(50 ng/ml)处理36小时组或λ磷酸酶处理后诺考达唑处理组,使用的抗体为Phospho-Rpb1 CTD (Ser2/5) Antibody (上图) 或 p53 Antibody #9282 (下图)。


RNA polymerase II is a complex of 12 proteins that participates in transcription, mRNA processing, and transcription-coupled DNA repair (1,2). The largest subunit, Rpb1, contains a unique heptapeptide: Tyr1, Ser2, Pro3, Thr4, Ser5, Pro6, Ser7, which is repeated up to 52 times in the carboxy-terminal domain (CTD) of Rpb1 (3). This CTD is phosphorylated by cyclin-dependent kinases (CDKs), p44/42 MAPK, DNA-PKcs, and c-Abl (4). DNA damage caused by UV-light, hydrogen peroxide, or cisplatin results in ubiquitination and proteasomal degradation of Rpb1 (1,3). The kinase inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole prevents ubiquitination of Rpb1, suggesting that CTD phosphorylation is required for proteolysis (5). RNA 聚合酶 II是由12种蛋白组成的复合体,参与转录、mRNA处理和转录偶联DNA修复(1,2)。最大的亚基Rpb1包含一个独特的七肽:Tyr1, Ser2, Pro3, Thr4, Ser5, Pro6, Ser7,在Rpb1的羧基末端结构域(CTD)发生高达52次的重复(3)。该结构域能够被周期蛋白依赖性激酶 (CDKs),p44/42 MAPK,DNA-PKcs和c-Abl 磷酸化(4)。紫外线、过氧化氢和顺铂引起的DNA损伤能够导致Rpb1的泛素化和蛋白酶体降解(1,3)。激酶抑制剂5,6-二氯-1-β-D-呋喃核糖基苯并咪唑能够阻止Rpb1的泛素化表明CTD磷酸化为蛋白酶解所必需(5)。

  1. Brookes, E. and Pombo, A. (2009) EMBO Rep 10, 1213-9.
  2. Komarnitsky, P. et al. (2000) Genes Dev 14, 2452-60.
  3. Ho, C.K. and Shuman, S. (1999) Mol Cell 3, 405-11.
  4. Ng, H.H. et al. (2003) Mol Cell 11, 709-19.
  5. Cheng, B. and Price, D.H. (2007) J Biol Chem 282, 21901-12.
  6. Marshall, N.F. et al. (1996) J Biol Chem 271, 27176-83.
  7. Krogan, N.J. et al. (2003) Mol Cell Biol 23, 4207-18.
  8. Proudfoot, N.J. et al. (2002) Cell 108, 501-12.
  9. Chapman, R.D. et al. (2007) Science 318, 1780-2.
  10. Egloff, S. et al. (2007) Science 318, 1777-9.
  11. Egloff, S. et al. (2008) Biochem Soc Trans 36, 590-4.
  12. Baillat, D. et al. (2005) Cell 123, 265-76.
  13. Akhtar, M.S. et al. (2009) Mol Cell 34, 387-93.
  14. Egloff, S. et al. (2010) J Biol Chem 285, 20564-9.
  15. Egloff, S. et al. (2012) Mol Cell 45, 111-22.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :